North Carolina Sate University is planning a 91,000-sf biomanufacturing test facility that will simulate a good-manufacturing-practices environment at its Raleigh campus. The $36-million facility, funded by a Golden Leaf grant, will provide workforce training for the biomanufacturing industry.
Genentech Corp. will locate 130 information technology employees in a 65,000-sf building recently purchased in Redwood City, Calif. The facility is located in the Mid-Point Technology Park, a site previously occupied by ExciteAtHome.
Cell Signaling Technology, based in Beverly, Mass., will renovate the 125-room Kings Grant Inn in Danvers, Mass., as its new headquarters facility. Cell Signaling is a biotechnology company that develops antibodies for cancer research.
United Therapeutics will construct a 40,000-sf ovarian cancer research lab and pharmaceutical manufacturing building adjacent to its headquarters in Silver Spring, Md. The $15-million lab is part of a 190,000-sf biotechnology campus planned by United Therapeutics. The new facility will manufacture OvaRex, an alternative to chemotherapy, in bulk for shipping to third-party manufacturers that will form it into pills.
Neurocrine Biosciences is developing the first phase of a 13.4-acre project in San Diego's Carmel Valley. Designed by Dowler Grumman Architects, the 200,000-sf, two-building project is being constructed by Ledcor Petty Construction.
